Home / Funds / Qube Research & Technologies Ltd.
Qube Research & Technologies Ltd.
Every short position this fund has disclosed, market by market.
Follow
0 open positions
0 Markets
August 20, 2026 Last disclosure
This fund discloses no open short position today.
Follow by RSS
Get the moves on Qube Research & Technologies Ltd. by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
1659 disclosures on record for this fund.| Date | Issuer | Market | % of capital | End of publication |
|---|
| August 17, 2023 | PostNL N.V. | Netherlands | 0.72% | |
| August 15, 2023 | Alfen N.V. | Netherlands | 1.10% | |
| August 15, 2023 | PostNL N.V. | Netherlands | 0.69% | |
| August 11, 2023 | PostNL N.V. | Netherlands | 0.70% | |
| August 10, 2023 | Alfen N.V. | Netherlands | 0.81% | |
| August 9, 2023 | Alfen N.V. | Netherlands | 0.79% | |
| August 8, 2023 | Bavarian Nordic A/S | Denmark | 1.33% | August 8, 2023 |
| August 7, 2023 | Galapagos NV | Netherlands | 0.51% | |
| August 7, 2023 | Lakefront Biotherapeutics NV | Netherlands | 0.51% | |
| July 31, 2023 | Alfen N.V. | Netherlands | 0.83% | |
| July 31, 2023 | Galapagos NV | Netherlands | 0.48% | |
| July 31, 2023 | Lakefront Biotherapeutics NV | Netherlands | 0.48% | |
| July 24, 2023 | Bavarian Nordic A/S | Denmark | 1.22% | July 24, 2023 |
| July 21, 2023 | Bavarian Nordic A/S | Denmark | 0.67% | July 21, 2023 |
| July 17, 2023 | PostNL N.V. | Netherlands | 0.69% | |
| July 13, 2023 | Alfen N.V. | Netherlands | 0.79% | |
| July 11, 2023 | Alfen N.V. | Netherlands | 0.88% | |
| July 10, 2023 | PostNL N.V. | Netherlands | 0.70% | |
| July 7, 2023 | Alfen N.V. | Netherlands | 0.92% | |
| July 7, 2023 | Bavarian Nordic A/S | Denmark | 0.71% | July 7, 2023 |
| July 7, 2023 | Galapagos NV | Netherlands | 0.59% | |
| July 7, 2023 | Lakefront Biotherapeutics NV | Netherlands | 0.59% | |
| July 6, 2023 | Alfen N.V. | Netherlands | 0.88% | |
| July 6, 2023 | Bavarian Nordic A/S | Denmark | 0.68% | July 6, 2023 |
| July 3, 2023 | PostNL N.V. | Netherlands | 0.60% | |
| June 30, 2023 | Alfen N.V. | Netherlands | 0.65% | |
| June 29, 2023 | Bavarian Nordic A/S | Denmark | 0.79% | June 29, 2023 |
| June 29, 2023 | Alfen N.V. | Netherlands | 0.70% | |
| June 29, 2023 | ALK-Abelló A/S | Denmark | 0.48% | June 29, 2023 |
| June 28, 2023 | Alfen N.V. | Netherlands | 0.69% | |
| June 28, 2023 | Galapagos NV | Netherlands | 0.60% | |
| June 28, 2023 | Lakefront Biotherapeutics NV | Netherlands | 0.60% | |
| June 26, 2023 | Alfen N.V. | Netherlands | 0.70% | |
| June 19, 2023 | ALK-Abelló A/S | Denmark | 0.54% | June 19, 2023 |
| June 16, 2023 | Bavarian Nordic A/S | Denmark | 0.84% | June 16, 2023 |
| June 16, 2023 | PostNL N.V. | Netherlands | 0.50% | |
| June 16, 2023 | AMG Critical Materials N.V. | Netherlands | 0.43% | |
| June 16, 2023 | NKT A/S | Denmark | 0.35% | June 16, 2023 |
| June 15, 2023 | Alfen N.V. | Netherlands | 0.69% | |
| June 15, 2023 | Galapagos NV | Netherlands | 0.59% | |
| June 15, 2023 | Lakefront Biotherapeutics NV | Netherlands | 0.59% | |
| June 15, 2023 | PostNL N.V. | Netherlands | 0.47% | |
| June 14, 2023 | PostNL N.V. | Netherlands | 0.56% | |
| June 13, 2023 | NKT A/S | Denmark | 0.67% | June 13, 2023 |
| June 13, 2023 | ChemoMetec A/S | Denmark | 0.52% | June 13, 2023 |
| June 13, 2023 | AMG Critical Materials N.V. | Netherlands | 0.50% | |
| June 12, 2023 | Alfen N.V. | Netherlands | 0.77% | |
| June 12, 2023 | Bavarian Nordic A/S | Denmark | 0.71% | June 12, 2023 |
| June 12, 2023 | AMG Critical Materials N.V. | Netherlands | 0.48% | |
| June 9, 2023 | Bavarian Nordic A/S | Denmark | 0.60% | June 9, 2023 |
Download 1659 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Qube Research & Technologies Ltd., data as at August 20, 2026, https://www.quivad.com/detenteur/qube-research-technologies-ltd?page=27